Hirotsu Bio Science Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 150

Employees

  • Latest Deal Type
  • Series C
  • (In Progress)

  • Latest Deal Amount
  • $60M

  • Investors
  • 18

Hirotsu Bio Science General Information

Description

Developer of a cancer detection technology designed to identify small amounts of cancerous odors in urine with high accuracy. The company offers a revolutionary, highly accurate, and comprehensive screening test that utilizes the sense of smell of living organisms, enabling individuals worldwide to access early and reliable detection of cancer for improved health outcomes.

Contact Information

Website
www.hbio.jp
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4-1 Kioicho Chiyoda-ku
  • 22F The New Otani Garden Court
  • Tokyo, Tokyo 102-0094
  • Japan
+81
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Distributors (Healthcare)
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 4-1 Kioicho Chiyoda-ku
  • 22F The New Otani Garden Court
  • Tokyo, Tokyo 102-0094
  • Japan
+81

Hirotsu Bio Science Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hirotsu Bio Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 01-Jan-2025 $60M In Progress Profitable
5. Later Stage VC Completed Profitable
4. Later Stage VC 01-Dec-2023 Completed Generating Revenue
3. Later Stage VC 16-Jul-2021 Completed Generating Revenue
2. Early Stage VC 26-Dec-2019 $36.6M $54.5M Completed Generating Revenue
1. Seed Round 07-Aug-2018 $17.9M $17.9M Completed Generating Revenue
To view Hirotsu Bio Science’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Hirotsu Bio Science Patents

  • 99

    Total Documents Applications and Grants

  • Total Patents Families

  • 78

    Granted

  • 19

    Pending

  • Expiring in next 12 mo

Hirotsu Bio Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4249910-A1 Blood sample testing method using taxis behavior of nematode Pending 17-Nov-2020
US-20230408496-A1 Blood sample testing method using taxis behavior of nematode Pending 17-Nov-2020
AU-2021383373-A1 Blood sample testing method using taxis behavior of nematode Pending 17-Nov-2020
AU-2021383373-A9 Blood sample testing method using taxis behavior of nematode Pending 17-Nov-2020
EP-4249910-A4 Blood sample testing method using taxis behavior of nematode Pending 17-Nov-2020 G01N33/5091
To view Hirotsu Bio Science’s complete patent history, request access »

Hirotsu Bio Science Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hirotsu Bio Science Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Data Business Supply Corporation Minority
NPH Holdings Corporation Minority
MS&AD Insurance Group Holdings Holding Company Minority
Aioi Nissay Dowa Insurance Corporation Minority
As One(Japan) Corporation Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Hirotsu Bio Science FAQs

  • When was Hirotsu Bio Science founded?

    Hirotsu Bio Science was founded in 2016.

  • Where is Hirotsu Bio Science headquartered?

    Hirotsu Bio Science is headquartered in Tokyo, Japan.

  • What is the size of Hirotsu Bio Science?

    Hirotsu Bio Science has 150 total employees.

  • What industry is Hirotsu Bio Science in?

    Hirotsu Bio Science’s primary industry is Diagnostic Equipment.

  • Is Hirotsu Bio Science a private or public company?

    Hirotsu Bio Science is a Private company.

  • What is the current valuation of Hirotsu Bio Science?

    The current valuation of Hirotsu Bio Science is .

  • What is Hirotsu Bio Science’s current revenue?

    The current revenue for Hirotsu Bio Science is .

  • How much funding has Hirotsu Bio Science raised over time?

    Hirotsu Bio Science has raised $125M.

  • Who are Hirotsu Bio Science’s investors?

    Data Business Supply, NPH Holdings, MS&AD Insurance Group Holdings, Aioi Nissay Dowa Insurance, and As One(Japan) are 5 of 18 investors who have invested in Hirotsu Bio Science.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »